Ritonavir Completed Phase 4 Trials for Human Immunodeficiency Virus (HIV) Infections Other

IndicationsStatusPurposePhase
CompletedOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT01388543Genetics and HIV-1 Protease Inhibitors